Establishing standardised methods for comparing aqueous droplet inhalers.

Area of Science:

• Pharmaceutical Sciences
• Respiratory Medicine
• Biomedical Engineering

Background:

• Aerosol inhalers are crucial for direct drug delivery to the respiratory system for patients with respiratory diseases.
• Current nebulizers deliver only a fraction of the loaded dose, with the inhalable dose being the portion inhaled by the patient.
• Understanding nebulizer performance is vital for optimizing drug delivery and patient outcomes.

Purpose of the Study:

• To fully characterize the performance of a breath-enhanced jet nebulizer.
• To assess the inhalable dose and droplet distribution under various breathing patterns and drug formulations.
• To highlight the variability in nebulizer performance based on these factors.

Main Methods:

• Testing a breath-enhanced jet nebulizer with multiple drug formulations.
• Evaluating nebulizer performance under different simulated breathing patterns.
• Measuring the inhalable dose and droplet size distribution of the generated aerosol.

Main Results:

• Significant variation in inhalable dose and droplet distribution was observed.
• Nebulizer performance was influenced by both the drug formulation and the breathing pattern.
• The breath-enhanced jet nebulizer showed inconsistent delivery across tested conditions.

Conclusions:

• A standardized protocol for evaluating nebulizers is essential.
• This protocol should incorporate breathing patterns relevant to intended use.
• Testing with a variety of formulations is necessary to reflect real-world clinical use.